Ocumetics Technology Corp (OTC) - Total Assets
Based on the latest financial reports, Ocumetics Technology Corp (OTC) holds total assets worth CA$1.15 Million CAD (≈ $834.97K USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Ocumetics Technology Corp investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Ocumetics Technology Corp - Total Assets Trend (2021–2025)
This chart illustrates how Ocumetics Technology Corp's total assets have evolved over time, based on quarterly financial data. Check tangible equity quality of Ocumetics Technology Corp to evaluate the tangible quality of the company's equity base.
Ocumetics Technology Corp - Asset Composition Analysis
Current Asset Composition (December 2025)
Ocumetics Technology Corp's total assets of CA$1.15 Million consist of 65.7% current assets and 34.3% non-current assets.
| Asset Category | Amount (CAD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 24.4% |
| Accounts Receivable | CA$0.00 | 0.0% |
| Inventory | CA$0.00 | 0.0% |
| Property, Plant & Equipment | CA$0.00 | 0.0% |
| Intangible Assets | CA$609.25K | 32.0% |
| Goodwill | CA$0.00 | 0.0% |
Asset Composition Trend (2021–2025)
This chart illustrates how Ocumetics Technology Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see OTC market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Ocumetics Technology Corp's current assets represent 65.7% of total assets in 2025, an increase from 13.7% in 2021.
- Cash Position: Cash and equivalents constituted 24.4% of total assets in 2025, up from 10.2% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 31.0% of total assets, a decrease from 75.0% in 2021.
- Asset Diversification: The largest asset category is intangible assets at 32.0% of total assets.
Ocumetics Technology Corp Competitors by Total Assets
Key competitors of Ocumetics Technology Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
|
China | CN¥12.68 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥29.91 Billion |
|
Pegavision
TW:6491
|
Taiwan | NT$16.17 Billion |
|
Tarsons Products Limited
NSE:TARSONS
|
India | Rs11.64 Billion |
|
SciVision Biotech Inc
TW:1786
|
Taiwan | NT$2.67 Billion |
|
Nyxoah
BR:NYXH
|
Belgium | €93.60 Million |
|
I.Ceram SA
PA:ALICR
|
France | €3.91 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.33 Billion |
Ocumetics Technology Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.98 | 3.42 | 0.49 |
| Quick Ratio | 0.98 | 3.42 | 0.49 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CA$-9.92K | CA$797.24K | CA$-195.43K |
Ocumetics Technology Corp - Advanced Valuation Insights
This section examines the relationship between Ocumetics Technology Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 400.96 |
| Latest Market Cap to Assets Ratio | 26.18 |
| Asset Growth Rate (YoY) | -18.0% |
| Total Assets | CA$1.90 Million |
| Market Capitalization | $49.86 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Ocumetics Technology Corp's assets at a significant premium (26.18x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Ocumetics Technology Corp's assets decreased by 18.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Ocumetics Technology Corp (2021–2025)
The table below shows the annual total assets of Ocumetics Technology Corp from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CA$1.90 Million ≈ $1.38 Million |
-18.01% |
| 2024-12-31 | CA$2.32 Million ≈ $1.68 Million |
+124.15% |
| 2023-12-31 | CA$1.04 Million ≈ $749.74K |
-24.56% |
| 2022-12-31 | CA$1.37 Million ≈ $993.83K |
+66.48% |
| 2021-12-31 | CA$825.25K ≈ $596.98K |
-- |
About Ocumetics Technology Corp
Ocumetics Technology Corp. engages in research, development, production, and sale of vision enhancement products in Canada. It develops expandable intraocular lenses to eliminate the need for corrective lenses primarily for people over 45 years of age. The company was formerly known as Quantum Blockchain Technologies Ltd. and changed its name to Ocumetics Technology Corp. in August 2021. The comp… Read more